Evidence map›Paper›PMID 39134988›Full record

ArticleJournal of nanobiotechnology2024

Oral administration of Robinia pseudoacacia L. flower exosome-like nanoparticles attenuates gastric and small intestinal mucosal ferroptosis caused by hypoxia through inhibiting HIF-1α- and HIF-2α-mediated lipid peroxidation.

Dezhi Wang, Heng Zhang, Xingchen Liao, Jun Li, Jie Zeng, Yilin Wang, Mingjie Zhang, Xianzong Ma, Xin Wang, Fangli Ren and 5 more

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. [SENP1 reduces ferroptosis of thyroid cancer cells by regulating hypoxia-inducible factor-1α].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  6. Chemical Constituents Comparison Between the Flowers ofMolecules (Basel, Switzerland) · 2026
    Article
  7. Ipriflavone FromMedComm · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Mediators of inflammation · 2026
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Dezhi Wang *Medical School of Chinese PLA, Chinese PLA General Hospital, Road Fuxing No. 28, Haidian District, Beijing, 100853, China.
Heng Zhang *Medical School of Chinese PLA, Chinese PLA General Hospital, Road Fuxing No. 28, Haidian District, Beijing, 100853, China.
Xingchen Liao *Medical School of Chinese PLA, Chinese PLA General Hospital, Road Fuxing No. 28, Haidian District, Beijing, 100853, China.
Jun LiState Key Laboratory of Membrane Biology, School of Medicine, Institute of Precision Medicine, Tsinghua University, Beijing, 100084, China.
Jie ZengDepartment of Urology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, China.
Yilin WangMedical School of Chinese PLA, Chinese PLA General Hospital, Road Fuxing No. 28, Haidian District, Beijing, 100853, China.
Mingjie ZhangDepartment of Gastroenterology, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, 100700, China.
Xianzong MaMedical School of Chinese PLA, Chinese PLA General Hospital, Road Fuxing No. 28, Haidian District, Beijing, 100853, China.
Xin WangDepartment of Gastroenterology, The Seventh Medical Center of Chinese PLA General Hospital, Beijing, 100700, China.
Fangli RenState Key Laboratory of Membrane Biology, School of Medicine, Institute of Precision Medicine, Tsinghua University, Beijing, 100084, China.
Yinyin WangState Key Laboratory of Membrane Biology, School of Medicine, Institute of Precision Medicine, Tsinghua University, Beijing, 100084, China.
Meng LiState Key Laboratory of Membrane Biology, School of Medicine, Institute of Precision Medicine, Tsinghua University, Beijing, 100084, China.
Junfeng XuSenior Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Road Fuxing No. 28, Haidian District, Beijing, 100853, China. 413791008@qq.com.
Peng JinSenior Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Road Fuxing No. 28, Haidian District, Beijing, 100853, China. jinpeng@301hospital.org.
Jianqiu ShengMedical School of Chinese PLA, Chinese PLA General Hospital, Road Fuxing No. 28, Haidian District, Beijing, 100853, China. shengjianqiu@301hospital.org.

Funding

National Natural Science Foundation of China 82170539The Special Project for Medical Innovation of the Health Bureau of the Logistics Support Department 18CXZ027
6 · The paper itself

Abstract

The prevention and treatment of gastrointestinal mucosal injury caused by a plateau hypoxic environment is a clinical conundrum due to the unclear mechanism of this syndrome; however, oxidative stress and microbiota dysbiosis may be involved. The Robinia pseudoacacia L. flower, homologous to a functional food, exhibits various pharmacological effects, such as antioxidant, antibacterial, and hemostatic activities. An increasing number of studies have revealed that plant exosome-like nanoparticles (PELNs) can improve the intestinal microbiota and exert antioxidant effects. In this study, the oral administration of Robinia pseudoacacia L. flower exosome-like nanoparticles (RFELNs) significantly ameliorated hypoxia-induced gastric and small intestinal mucosal injury in mice by downregulating hypoxia-inducible factor-1α (HIF-1α) and HIF-2α expression and inhibiting hypoxia-mediated ferroptosis. In addition, oral RFELNs partially improved hypoxia-induced microbial and metabolic disorders of the stomach and small intestine. Notably, RFELNs displayed specific targeting to the gastrointestinal tract. In vitro experiments using gastric and small intestinal epithelial cell lines showed that cell death caused by elevated HIF-1α and HIF-2α under 1% O

Indexed as

Basic Helix-Loop-Helix ProteinsExosomesFerroptosisFlowersGastric MucosaHypoxia-Inducible Factor 1, alpha SubunitIntestinal MucosaIntestine, SmallLipid PeroxidationNanoparticlesAdministration, OralAnimalsEndothelial PAS Domain-Containing Protein 1HumansHypoxiaMaleBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1Hif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitArachidonate lipoxygenase 5 (ALOX5)FerroptosisHypoxiaHypoxia-inducible factor (HIF)Nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4)Robinia pseudoacacia L. flower exosome-like nanoparticlesSmall intestineStomach

Identifiers

PMID39134988
PMCPMC11321022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.